期刊
CANCER JOURNAL
卷 18, 期 2, 页码 148-152出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/PPO.0b013e31824bd256
关键词
Uveal melanoma; GNAQ; GNA11; BAP1
类别
资金
- National Cancer Institute [P50CA093459]
- National Institutes of Health [K12CA088084]
- GlaxoSmithKline
- Bristol Myers Squibb
Uveal melanoma is the most common primary intraocular cancer in adults. Nearly half of primary uveal melanoma tumors metastasize, but there are currently no effective therapies for metastatic uveal melanoma. The recent discovery of mutations that underlie uveal melanoma metastasis, growth, and survival provide a key to the molecular understanding of this disease. Much work is now underway to leverage this knowledge to develop effective therapies. This review summarizes recently discovered molecular features of uveal melanoma and therapies being explored to capitalize on this knowledge.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据